Literature DB >> 33134438

Management of Oligometastatic Prostate Cancer.

James R Broughman1, Christopher W Fleming1, Omar Y Mian1, Kevin L Stephans1, Rahul D Tendulkar1.   

Abstract

Entities:  

Year:  2020        PMID： 33134438      PMCID： PMC7595346     

Source DB:  PubMed          Journal:  Appl Radiat Oncol        ISSN： 2334-5446


× No keyword cloud information.
  34 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

Review 2.  Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.

Authors:  Guillaume Ploussard; Giorgio Gandaglia; Hendrik Borgmann; Pieter de Visschere; Isabel Heidegger; Alexander Kretschmer; Romain Mathieu; Cristian Surcel; Derya Tilki; Igor Tsaur; Massimo Valerio; Roderick van den Bergh; Piet Ost; Alberto Briganti
Journal:  Eur Urol       Date:  2018-10-31       Impact factor: 20.096

3.  Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.

Authors:  Kim N Chi; Neeraj Agarwal; Anders Bjartell; Byung Ha Chung; Andrea J Pereira de Santana Gomes; Robert Given; Álvaro Juárez Soto; Axel S Merseburger; Mustafa Özgüroğlu; Hirotsugu Uemura; Dingwei Ye; Kris Deprince; Vahid Naini; Jinhui Li; Shinta Cheng; Margaret K Yu; Ke Zhang; Julie S Larsen; Sharon McCarthy; Simon Chowdhury
Journal:  N Engl J Med       Date:  2019-05-31       Impact factor: 91.245

4.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

5.  No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.

Authors:  Jennifer N Wu; Kari M Fish; Christopher P Evans; Ralph W Devere White; Marc A Dall'Era
Journal:  Cancer       Date:  2013-11-20       Impact factor: 6.860

6.  Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.

Authors:  B Jeremic; Y Shibamoto; N Nikolic; B Milicic; S Milisavljevic; A Dagovic; J Aleksandrovic; G Radosavljevic-Asic
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

7.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

8.  Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.

Authors:  Amila Siriwardana; James Thompson; Pim J van Leeuwen; Shaela Doig; Anton Kalsbeek; Louise Emmett; Warick Delprado; David Wong; Hemamali Samaratunga; Anne-Maree Haynes; Geoff Coughlin; Phillip Stricker
Journal:  BJU Int       Date:  2017-06-20       Impact factor: 5.588

9.  Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.

Authors:  Rajendra Badwe; Rohini Hawaldar; Nita Nair; Rucha Kaushik; Vani Parmar; Shabina Siddique; Ashwini Budrukkar; Indraneel Mittra; Sudeep Gupta
Journal:  Lancet Oncol       Date:  2015-09-09       Impact factor: 41.316

10.  Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Authors:  Arnaud Méjean; Alain Ravaud; Simon Thezenas; Sandra Colas; Jean-Baptiste Beauval; Karim Bensalah; Lionnel Geoffrois; Antoine Thiery-Vuillemin; Luc Cormier; Hervé Lang; Laurent Guy; Gwenaelle Gravis; Frederic Rolland; Claude Linassier; Eric Lechevallier; Christian Beisland; Michael Aitchison; Stephane Oudard; Jean-Jacques Patard; Christine Theodore; Christine Chevreau; Brigitte Laguerre; Jacques Hubert; Marine Gross-Goupil; Jean-Christophe Bernhard; Laurence Albiges; Marc-Olivier Timsit; Thierry Lebret; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245
View more
  2 in total

1.  Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.

Authors:  Diane K Reyes; Bruce J Trock; Phuoc T Tran; Christian P Pavlovich; Curtiland Deville; Mohamad E Allaf; Stephen C Greco; Daniel Y Song; Trinity J Bivalacqua; Misop Han; Alan W Partin; A Oliver Sartor; Steven P Rowe; Kenneth J Pienta
Journal:  Med Oncol       Date:  2022-04-28       Impact factor: 3.064

Review 2.  Imaging of Oligometastatic Disease.

Authors:  Naik Vietti Violi; Rami Hajri; Laura Haefliger; Marie Nicod-Lalonde; Nicolas Villard; Clarisse Dromain
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.